Spondyloarthritis & psoriatic arthritis
Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors’ Self‐Citation Rate in Japan and the United States
Study context
- Population
- All authors of psoriatic arthritis (PsA) clinical practice guideline (CPGs) issued by the Japanese Dermatological Association (JDA) and American College of Rheumatology (ACR), Japan and the US, 2016–2018
- Participants
- 23 vs 25
- Exposure
- PsA CPG authors in Japan vs the US
- JDAn = 23
- ACRn = 25
- Outcome
- Financial and nonfinancial conflicts of interest (COI) of PsA CPG authors; quality of evidence and strength of recommendations
- Follow-up
- 2016–2018
Methodological detailspayment data from major Japanese pharmaceutical companies and US Open Payments Database, 2016–2018
- Payment data from major Japanese pharmaceutical companies and US Open Payments Database, 2016–2018
Main finding
As reported in the abstract
CPG authors receiving at least 1 payment from pharmaceutical companies
| Group | Value | Combined total payment |
|---|---|---|
| Japan | 91.3% | $3,335,413 |
| US | 84.0% | $4,081,629 |
Value
Japan91.3%
US84.0%
Combined total payment
Japan$3,335,413
US$4,081,629
Observational data: associations, not effects.
Further findings
Authors with undisclosed financial COI
Undisclosed financial COI worth JDA $474,663 · ACR $218,501
Recommendations supported by low or very low quality of evidence
- 3-year combined payment per author: Japan mean 145,018 (SD 114,302) $
- 3-year combined payment per author: US mean 162,825 (SD 259,670) $
- Citations with at least 1 CPG author relative to total citations (self-citation): Japan 3.4%
- Citations with at least 1 CPG author relative to total citations (self-citation): US 33.6%
Original publication
Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors’ Self‐Citation Rate in Japan and the United States. Arthritis Care Res (Hoboken). Published 14 January 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →